updated 7/18/2006 11:17:03 AM ET 2006-07-18T15:17:03

Johnson & Johnson's profit rose nearly 9 percent in the second quarter as record sales and restrained spending on marketing and overhead costs offset higher research expenses.

Major Market Indices

The diversified health products maker on Tuesday reported net income grew to $2.82 billion, or 95 cents per share, in the April-June peirod from $2.59 billion, or 86 cents per share, during the same quarter a year ago.

Excluding an $87 million charge for an acquisition, the company would have posted net income of $2.9 billion, or 98 cents per share. That beat by a penny a share the consensus forecast of analysts surveyed by Thomson Financial.

J&J, which makes products ranging from contact lenses and contraceptives to baby shampoo and skincare lotions, said revenue rose 4.7 percent, to $13.4 billion from $12.8 billion a year earlier.

Analysts had expected sales of $13.3 billion for the latest quarter.

Copyright 2006 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com